Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate

British Journal of Pharmacology

Volumn 159, Issue 4, 2010, Pages 797-807

  Parker, Lauren K ^a   Shanks, Julia A ^a   Kennard, James A G ^a   Brain, Keith L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cholinergic receptors; Confocal; Fluorescence; NET; Noradrenaline; Sympathetic

Indexed keywords

AMPHETAMINE; CARBACHOL; DESIPRAMINE; ENHANCED GREEN FLUORESCENT PROTEIN; MUSCARINIC RECEPTOR; NEUROTRANSMITTER TRANSPORTER; NORADRENALIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; MOUSE; NEUROTRANSMITTER UPTAKE; NONHUMAN; PRIORITY JOURNAL; SYMPATHETIC NERVE; VAS DEFERENS;

ADRENERGIC FIBERS; ADRENERGIC UPTAKE INHIBITORS; AMPHETAMINE; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; DESIPRAMINE; DEXTRANS; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FLUORESCENT DYES; GREEN FLUORESCENT PROTEINS; KINETICS; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MOLECULAR IMAGING; MOLECULAR PROBE TECHNIQUES; MUSCLE CONTRACTION; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ORGANIC CHEMICALS; PRESYNAPTIC TERMINALS; RECEPTORS, MUSCARINIC; RECEPTORS, PRESYNAPTIC; RECOMBINANT FUSION PROTEINS; REPRODUCIBILITY OF RESULTS; RESERPINE; VAS DEFERENS;

EID: 77249149995     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00574.x     Document Type: Article

References (40)

1. Alexander SP, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD (1998a). Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Ther 287 : 733 743.
3. Apparsundaram S, Schroeter S, Giovanetti E, Blakely RD (1998b). Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. J Pharmacol Exp Ther 287 : 744 751.
4. Backs J, Bresch E, Lutz M, Kristen AV, Haass M (2005). Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats. Cardiovasc Res 67 : 283 290.
5. Baldessarini RJ (2001). Drugs and the treatment of psychiatric disorders. In : Hardman JG, Limbird LE (eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics, 10th edn. McGraw-Hill : New York, pp. 447 483.
6. Bauman AL, Apparsundaram S, Ramamoorthy S, Wadzinski BE, Vaughan RA, Blakely RD (2000). Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J Neurosci 20 : 7571 7578.
7. Bradley L, Doggrell SA (1985). Modification by desipramine of the effects of alpha-adrenoceptor antagonists on the contractile responses of the trisected rat vas deferens. Gen Pharmacol 16 : 475 482.
8. Brain KL, Bennett MR (1997). Calcium in sympathetic varicosities of mouse vas deferens during facilitation, augmentation and autoinhibition. J Physiol 502 : 521 536.
9. Brain KL, Cunnane TC (2008). Bretylium abolishes neurotransmitter release without necessarily abolishing the nerve terminal action potential in sympathetic terminals. Br J Pharmacol 153 : 831 839.
10. Brain KL, Trout SJ, Jackson VM, Dass N, Cunnane TC (2001). Nicotine induces calcium spikes in single nerve terminal varicosities: a role for intracellular calcium stores. Neuroscience 106 : 395 403.
11. 2+ transients in mouse vas deferens. J Physiol 541 : 849 862.
12. 2A/D-adrenoceptor knockout mice. Br J Pharmacol 138 : 1069 1076.
13. Cuprian AM, Solanki P, Jackson MV, Cunnane TC (2005). Cholinergic innervation of the mouse isolated vas deferens. Br J Pharmacol 146 : 927 934.
14. Cuprian-Beltechi AM, Solanki P, Teramoto N, Cunnane TC (2009). High spatial resolution studies of muscarinic neuroeffector junctions in mouse isolated vas deferens. Neuroscience 162 : 1366 1376.
15. Glowniak JV, Kilty JE, Amara SG, Hoffman BJ, Turner FE (1993). Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med 34 : 1140 1146.
16. Gosling JA, Dixon JS (1972). Differences in the manner of autonomic innervation of the muscle layers of the guinea-pig ductus deferens. J Anat 112 : 81 91.
17. Hamberger B, Malmfors T, Norberg KA, Sachs C (1964). Uptake and accumulation of catecholamines in peripheral adrenergic neurons of reserpinized animals, studied with a histochemical method. Biochem Pharmacol 13 : 841 844.
18. Iversen LL (1967). The Uptake and Storage of Noradrenaline in Sympathetic Nerves. Cambridge University Press : London.
19. Jayanthi LD, Annamalai B, Samuvel DJ, Gether U, Ramamoorthy S (2006). Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization. J Biol Chem 281 : 23326 23340.
20. Jørgensen S, Nielsen EO, Peters D, Dyhring T (2008). Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity. J Neurosci Methods 169 : 168 176.
21. Kaleczyc J (1998). Origin and neurochemical characteristics of nerve fibres supplying the mammalian vas deferens. Microsc Res Tech 42 : 409 422.
22. Kaschube M, Zetler G (1989). Noradrenergic, purinergic, and cholinergic transmission in the mouse vas deferens: influence of field-stimulation parameters, reserpinization, 6-hydroxydopamine and 4aminopyridine. J Neural Transm 76 : 39 53.
23. Kaye DM, Gruskin S, Smith AI, Esler MD (2000). Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S-nitrosylation. Br J Pharmacol 130 : 1060 1064.
24. Kihara K (1998). Introduction to innervation of the vas deferens. Microsc Res Tech 42 : 387 389.
25. Kihara K, Sato K, Oshima H (1998). Sympathetic efferent pathways projecting to the vas deferens. Microsc Res Tech 42 : 398 408.
26. Kopin IJ, Hertting G, Gordon EK (1962). Fate of norepinephrine-H3 in the isolated perfused rat heart. J Pharmacol Exp Ther 138 : 34 40.
27. Ksiazek P, Buraczynska K, Buraczynska M (2006). Norepinephrine transporter gene (NET) polymorphism in patients with type 2 diabetes. Kidney Blood Press Res 29 : 338 343.
28. 2+ transients during neurogenic contractions of rat mesenteric small arteries. J Physiol 549 : 801 808.
29. Mason JN, Farmer H, Tomlinson ID, Schwartz JW, Savchenko V, DeFelice LJ et al. (2005). Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation. J Neurosci Methods 143 : 3 25.
30. Moura D, Azevedo I, Guimaraes S (1990). Differential distribution in, and release from, sympathetic nerve endings of endogenous noradrenaline and recently incorporated catecholamines. Naunyn Schmiedebergs Arch Pharmacol 342 : 153 159.
31. Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA (1995). Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 47 : 368 373.
32. Ross SB, Gosztonyi T (1975). On the mechanism of the accumulation of 3H-bretylium in peripheral sympathetic nerves. Naunyn Schmiedebergs Arch Pharmacol 288 : 283 293.
33. Schroeter S, Apparsundaram S, Wiley RG, Miner LH, Sesack SR, Blakely RD (2000). Immunolocalization of the cocaine-and antidepressant-sensitive l-norepinephrine transporter. J Comp Neurol 420 : 211 232.
34. Schwartz JW, Blakely RD, DeFelice LJ (2003). Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate. J Biol Chem 278 : 9768 9777.
35. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I et al. (2000). Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342 : 541 549.
36. Sung U, Apparsundaram S, Galli A, Kahlig KM, Savchenko V, Schroeter S et al. (2003). A regulated interaction of syntaxin 1A with the antidepressant- sensitive norepinephrine transporter establishes catecholamine clearance capacity. J Neurosci 23 : 1697 1709.
37. Sung U, Blakely RD (2007). Calcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A. Mol Cell Neurosci 34 : 251 260.
38. Varoqui H, Erickson JD (1997). Vesicular neurotransmitter transporters. Potential sites for the regulation of synaptic function. Mol Neurobiol 15 : 165 191.
39. Williams DJ, Brain KL, Cunnane TC (2007). The effect of epibatidine on spontaneous and evoked neurotransmitter release in the mouse and guinea pig isolated vas deferens. Br J Pharmacol 150 : 906 912.
40. Yaris E, Kesim M, Kadioglu M, Kalyoncu NI, Ulku C, Ozyavuz R (2003). The effects of paroxetine on rat isolated vas deferens. Pharmacol Res 48 : 335 345.